JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spanu, A.
Right arrow Articles by Madeddu, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spanu, A.
Right arrow Articles by Madeddu, G.
Journal of Nuclear Medicine Vol. 45 No. 1 40-48
© 2004 by Society of Nuclear Medicine


Clinical Investigations

The Usefulness of Neck Pinhole SPECT as a Complementary Tool to Planar Scintigraphy in Primary and Secondary Hyperparathyroidism

Angela Spanu, MD1, Antonio Falchi, MD1, Alessandra Manca, MD2, Pietro Marongiu, MD1, Antonio Cossu, MD2, Nicola Pisu, MD1, Francesca Chessa, MD1, Susanna Nuvoli, MD1 and Giuseppe Madeddu, MD1

1 Department of Nuclear Medicine, University of Sassari, Sassari, Italy
2 Department of Histopathology, University of Sassari, Sassari, Italy

Pinhole SPECT (P-SPECT) has proven to be a high-resolution and sensitive method in both experimental and clinical studies. In this study, we investigated whether P-SPECT combined with conventional planar scintigraphy can give additional information in hyperfunctioning parathyroid gland detection in both primary hyperparathyroidism (pHPT) and secondary hyperparathyroidism (sHPT) since planar imaging has proved partially limited, especially in sHPT. Methods: We studied 110 consecutive patients with HPT, selecting 67 patients who underwent neck surgery and had definitive histology: 48 with pHPT and 19 with sHPT. All patients underwent planar scintigraphy, 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) double-phase scintigraphy (n = 22) or 99mTc-tetrofosmin subtraction scintigraphy (n = 45), using a {gamma}-camera with a parallel-hole collimator. P-SPECT was then performed (180°; matrix size, 128 x 128; zoom factor, 2; time per frame, 40 s) using a tilted detector equipped with a pinhole collimator (insert, 4.45 mm). Results: In the 48 pHPT patients, 49 lesions (43 adenomas, 1 carcinoma, and 5 hyperplastic glands, including 1 intrathyroidal) were found at surgery; in the 19 sHPT patients, 51 lesions (49 hyperplastic glands, including 1 in persistens thymus, and 2 adenomas) were found. P-SPECT proved to be a highly sensitive method, identifying more lesions than planar imaging in both pHPT (97.9% vs. 87.7%) and sHPT (92.1% vs. 78.4%), significantly (P < 0.05) in the latter. P-SPECT, positive in all adenomas, increased planar sensitivity especially in small and light-weight ones, 30.8% of which missed on planar imaging, and also identified a significantly higher number of hyperplastic glands, irrespective of their size. P-SPECT improved image quality and resolution, offering a more correct lesion localization in eutopic and ectopic sites. Neither P-SPECT nor planar imaging had false-positive findings. Moreover, P-SPECT correctly predicted the status found at surgery in 97.9% of pHPT patients and in 82.3% of sHPT patients with multigland disease, whereas planar imaging correctly predicted the status in 89.6% and 58.8%, respectively. P-SPECT was the only positive procedure in 8.9% of all patients, also revealing more lesions in 6% of sHPT patients when both methods were positive. Conclusion: P-SPECT appears a highly sensitive, high-resolution method. We suggest its use as a preoperative complementary tool to neck planar scintigraphy, selectively in pHPT patients but extensively in sHPT patients.

Key Words: pinhole SPECT • parathyroid scintigraphy • hyperparathyroidism • parathyroid adenomas • hyperplastic parathyroid glands




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
N. Hara, T. Takayama, M. Onoguchi, N. Obane, T. Miyati, T. Yoshioka, K. Sakaguchi, and M. Honda
Subtraction SPECT for Parathyroid Scintigraphy Based on Maximization of Mutual Information
J. Nucl. Med. Technol., June 1, 2007; 35(2): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
N. A. Johnson, M. E. Tublin, and J. B. Ogilvie
Parathyroid Imaging: Technique and Role in the Preoperative Evaluation of Primary Hyperparathyroidism
Am. J. Roentgenol., June 1, 2007; 188(6): 1706 - 1715.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
J. M. Ruda, B. C. Stack Jr, and C. S. Hollenbeak
The Cost-effectiveness of Additional Preoperative Ultrasonography or Sestamibi-SPECT in Patients With Primary Hyperparathyroidism and Negative Findings on Sestamibi Scans
Arch Otolaryngol Head Neck Surg, January 1, 2006; 132(1): 46 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S J Johnson, E A Sheffield, and A M McNicol
BEST PRACTICE NO 183: Examination of parathyroid gland specimens
J. Clin. Pathol., April 1, 2005; 58(4): 338 - 342.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. W. Gayed, E. E. Kim, W. F. Broussard, D. Evans, J. Lee, L. D. Broemeling, B. B. Ochoa, D. M. Moxley, W. D. Erwin, and D. A. Podoloff
The Value of 99mTc-Sestamibi SPECT/CT over Conventional SPECT in the Evaluation of Parathyroid Adenomas or Hyperplasia
J. Nucl. Med., February 1, 2005; 46(2): 248 - 252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.